FDA recall D-0465-2025 · initiated Apr 14, 2025
Most serious — a reasonable probability that use will cause serious harm or death.
Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.